The Prometheus League
Breaking News and Updates
- Abolition Of Work
- Ai
- Alt-right
- Alternative Medicine
- Antifa
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ascension
- Astronomy
- Atheism
- Atheist
- Atlas Shrugged
- Automation
- Ayn Rand
- Bahamas
- Bankruptcy
- Basic Income Guarantee
- Big Tech
- Bitcoin
- Black Lives Matter
- Blackjack
- Boca Chica Texas
- Brexit
- Caribbean
- Casino
- Casino Affiliate
- Cbd Oil
- Censorship
- Cf
- Chess Engines
- Childfree
- Cloning
- Cloud Computing
- Conscious Evolution
- Corona Virus
- Cosmic Heaven
- Covid-19
- Cryonics
- Cryptocurrency
- Cyberpunk
- Darwinism
- Democrat
- Designer Babies
- DNA
- Donald Trump
- Eczema
- Elon Musk
- Entheogens
- Ethical Egoism
- Eugenic Concepts
- Eugenics
- Euthanasia
- Evolution
- Extropian
- Extropianism
- Extropy
- Fake News
- Federalism
- Federalist
- Fifth Amendment
- Fifth Amendment
- Financial Independence
- First Amendment
- Fiscal Freedom
- Food Supplements
- Fourth Amendment
- Fourth Amendment
- Free Speech
- Freedom
- Freedom of Speech
- Futurism
- Futurist
- Gambling
- Gene Medicine
- Genetic Engineering
- Genome
- Germ Warfare
- Golden Rule
- Government Oppression
- Hedonism
- High Seas
- History
- Hubble Telescope
- Human Genetic Engineering
- Human Genetics
- Human Immortality
- Human Longevity
- Illuminati
- Immortality
- Immortality Medicine
- Intentional Communities
- Jacinda Ardern
- Jitsi
- Jordan Peterson
- Las Vegas
- Liberal
- Libertarian
- Libertarianism
- Liberty
- Life Extension
- Macau
- Marie Byrd Land
- Mars
- Mars Colonization
- Mars Colony
- Memetics
- Micronations
- Mind Uploading
- Minerva Reefs
- Modern Satanism
- Moon Colonization
- Nanotech
- National Vanguard
- NATO
- Neo-eugenics
- Neurohacking
- Neurotechnology
- New Utopia
- New Zealand
- Nihilism
- Nootropics
- NSA
- Oceania
- Offshore
- Olympics
- Online Casino
- Online Gambling
- Pantheism
- Personal Empowerment
- Poker
- Political Correctness
- Politically Incorrect
- Polygamy
- Populism
- Post Human
- Post Humanism
- Posthuman
- Posthumanism
- Private Islands
- Progress
- Proud Boys
- Psoriasis
- Psychedelics
- Putin
- Quantum Computing
- Quantum Physics
- Rationalism
- Republican
- Resource Based Economy
- Robotics
- Rockall
- Ron Paul
- Roulette
- Russia
- Sealand
- Seasteading
- Second Amendment
- Second Amendment
- Seychelles
- Singularitarianism
- Singularity
- Socio-economic Collapse
- Space Exploration
- Space Station
- Space Travel
- Spacex
- Sports Betting
- Sportsbook
- Superintelligence
- Survivalism
- Talmud
- Technology
- Teilhard De Charden
- Terraforming Mars
- The Singularity
- Tms
- Tor Browser
- Trance
- Transhuman
- Transhuman News
- Transhumanism
- Transhumanist
- Transtopian
- Transtopianism
- Ukraine
- Uncategorized
- Vaping
- Victimless Crimes
- Virtual Reality
- Wage Slavery
- War On Drugs
- Waveland
- Ww3
- Yahoo
- Zeitgeist Movement
-
Prometheism
-
Forbidden Fruit
-
The Evolutionary Perspective
Category Archives: Transhuman News
Psoriasis Drug Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- AbbVie, Johnson &…
Posted: March 21, 2021 at 4:36 pm
DataIntelo has included a latest report on the Global Psoriasis Drug Market into its archive of market research studies. The report is an amalgamation of detailed market overview based on the segmentations, applications, trends and opportunities, mergers and acquisitions, drivers, and restraints. The report showcases the current and forthcoming technical and financial details of the Psoriasis Drug market. The research study attracts attention to a detailed synopsis of the market valuation, revenue estimation, and market statistics. The study on the emerging trends in the global and regional spaces on all the significant components, such as market capacity, cost, price, demand and supply, production, profit, and competitive landscape. The report also explores all the key factors affecting the growth of the global market, consisting of the demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.
Some of the major companies that are covered in this report:
*Note: Additional companies can be included on request
Get a free exclusive sample report of Psoriasis Drug market @ https://dataintelo.com/request-sample/?reportId=88617
Impact of COVID-19
The report also talks about the impact of the ongoing global crisis i.e., COVID-19 on the Psoriasis Drug market and explains how the future is going to unfold for the global market. Our analysts have researched thoroughly about the effects of the pandemic on the global economy. The outbreak has directly affected production and demand disrupted the demand and supply chain. The report also computes the financial impact on firms and financial markets. DataIntelo has accumulated insights from several delegates of the industry and got involved in the primary and secondary research to offer the clients data & strategies to combat the market challenges during and after the COVID-19 pandemic.
Highlights of the report:
Our research analysts who are the building blocks of the company have worked extensively to fabricate the research report which will give that extra edge to our clients business in the competitive market. The market research report can be customized as per you and your needs. This means that DataIntelo can cover a particular product, application, or can offer a detailed analysis in the report. You can also buy a separate report for a specific region.
You can buy the complete report in PDF format: @ https://dataintelo.com/checkout/?reportId=88617
The market scenario is likely to be fairly competitive. To analyze any market with simplicity the market is fragmented into the following segments:
By Applications:
By Types:
By Regions:
Segmenting the market into smaller components helps in analyzing the dynamics of the market with more clarity. Another key component that is integrated into the report is the regional analysis to assess the global presence of the Psoriasis Drug market. You can also opt for a yearly subscription of all the updates on the Psoriasis Drug market.
If you have any questions on this report, feel free to reach us! @ https://dataintelo.com/enquiry-before-buying/?reportId=88617
Below is the TOC of the report:
Executive Summary
Assumptions and Acronyms Used
Research Methodology
Psoriasis Drug Market Overview
Global Psoriasis Drug Market Analysis and Forecast by Type
Global Psoriasis Drug Market Analysis and Forecast by Application
Global Psoriasis Drug Market Analysis and Forecast by Sales Channel
Global Psoriasis Drug Market Analysis and Forecast by Region
North America Psoriasis Drug Market Analysis and Forecast
Latin America Psoriasis Drug Market Analysis and Forecast
Europe Psoriasis Drug Market Analysis and Forecast
Asia Pacific Psoriasis Drug Market Analysis and Forecast
Asia Pacific Psoriasis Drug Market Size and Volume Forecast by Application
Middle East & Africa Psoriasis Drug Market Analysis and Forecast
Competition Landscape
Avail exclusive discount on this report @ https://dataintelo.com/ask-for-discount/?reportId=88617
About DataIntelo:
DataIntelo has a vast experience in making customized market research reports in a number of industry verticals. We strive for complete client satisfaction. We cover in-depth market analysis, which consists of stipulating lucrative business strategies, especially for the new entrants and the emerging players of the market. Our team makes sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch.
We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.
Contact Info:
Name: Alex Mathews
Address: 500 East E Street, Ontario,
CA 91764, United States.
Phone No: USA: +1 909 545 6473
Email:[emailprotected]
Website:https://dataintelo.com
Posted in Psoriasis
Comments Off on Psoriasis Drug Market 2021 Will Reflect Significant Growth in Future with Size, Share, Growth, and Key Companies Analysis- AbbVie, Johnson &…
Applied Therapeutics to Host Virtual Rare Disease Forum – GlobeNewswire
Posted: at 4:36 pm
NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced it will host a Virtual Rare Disease Forum on Tuesday, March 23rd, 2021 from 1:00pm to 3:00pm ET. The event will highlight Applied Therapeutics development programs in Galactosemia, SORD Deficiency, and PMM2-CDG. The agenda for the event will include:
Were excited to host this event to spotlight our clinical development programs in Galactosemia, SORD and PMM2-CDG, saidShoshana Shendelman, PhD, Founder, CEO and Chair of the Board of Applied Therapeutics. We believe that AT-007 represents an important advancement for patients with these rare diseases, and our clinical development programs offer a unique opportunity to meaningfully impact patients lives.
An audio webcast of the presentation will be available live. More details will be available at http://ir.appliedtherapeutics.com leading up to the event. An archived version of the presentation will be available following the event.
AboutApplied TherapeuticsApplied Therapeuticsis a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Companys lead drug candidate, AT-007, is a novel central nervous system penetrant aldose reductase inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric metabolic disease. The Company initiated a pivotal Phase 1/2 clinical trial inJune 2019, read out positive top-line biomarker data in adult Galactosemia patients inJanuary 2020and announced full data from the trial inApril 2020. A pediatric Galactosemia study commenced inJune 2020. The Company is also developing AT-001, a novel potent ARI that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The Company initiated a Phase 3 registrational study in DbCM inSeptember 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, as well as novel dual PI3k inhibitors in preclinical development for orphan oncology indications.
To learn more, please visit http://www.appliedtherapeutics.com and follow the company on Twitter @Applied_Tx.
Investors:Maeve Conneighton(212) 600-1902 orappliedtherapeutics@argotpartners.com
Media:media@appliedtherapeutics.com
More:
Applied Therapeutics to Host Virtual Rare Disease Forum - GlobeNewswire
Posted in Human Genetics
Comments Off on Applied Therapeutics to Host Virtual Rare Disease Forum – GlobeNewswire
Pokin Around: A visit from an old friend cycling the Mother Road to collect COVID stories – News-Leader
Posted: at 4:36 pm
Mike Comerford is one of those people you meet in life that you never forget andhope that fortune is kind enough that you'll meet again.
Prior to this week, I had last seen him in 1987. That's when he jumped at the chance to take a road trip to Warwick, New York to of all things help me and my wife move there.
I had taken a new job at a bigger paper. Mike and I had worked together at the daily paper in Elgin, Illinois.
Back then, he says, he was 6-foot-5. He's lost an inch to age. He's 62.
Mike Comerford, 62, worked with News-Leader columnist Steve Pokin in the newsroom of the Elgin (Illinois) Courier-News. The paper no longer exists. They had not seen each other since 1987 until this week. Comerford is biking Route 66 to Los Angeles as he collects COVID-19 stories.(Photo: Steve Pokin/News-Leader)
Back then, I had dark hair. I'm 67.
Our lives have taken different paths, but the bedrock of our friendship has remained true. After all these years, we're both still writing.
Mike is riding a bicycle that he estimates to be 40 to 50 years old along Route 66. He started in Chicago in late February and is headed to Los Angeles.
Along the way, he collects COVID-19 stories from everydaypeople he meets.
More: Pokin Around: Sheriff says same wayward cattle a regular problem; called in some 'cowboys'
Mike has interview subjects sign a release and asks them a few questions and videotapes their answers for some five minutes.
In this project, I am finding people incredibly articulate. You can not make up about how articulate people are about their lives. They start out by saying, I have nothing to say. And then, before you know it, they have these beautiful stories heartbreaking, exuberant, compelling and emotional.
"... I'm capturing the unique stories of people living with COVID, as opposed to all the obituaries."
With thunder, lightning and rain in the forecast, Mike Comerford leaves my driveway Wednesday morning en route to Los Angeles along Route 66. He is collecting stories from everyday people about COVID-19 and the pandemic. He hopes to make them into a book.(Photo: Steve Pokin/News-Leader)
I picked him up Tuesday at the Library Center on South Campbell. He spends much time in public libraries posting about his journey and, when needed, getting out of the weather.
The night before he stayed in a hotel in Seymour. He spends half his nights on the road in cheap hotels and the other half wrapped in a sleeping bag, in a small tent he pitches in a cemetery, park or forest preserve.
His odyssey is purely speculative. He will write a book. That's for sure. But the speculative part is whether it will make money.
Prior to this week, the last time News-Leader columnist Steve Pokin, left, saw Mike Comerford was in 1987. Pokin left the Courier-News in Elgin, Illinois, to take a job at a bigger paper in Middletown, N.Y. Comerford was quick to volunteer to help with the move and made the trip.(Photo: Steve Pokin/News-Leader)
He has no financial sponsor, but he is telling these stories with the help of the University of Florida'sSamuel Proctor Oral History Program. They liked the idea of a guy riding a bicycle on the Mother Road collecting pandemic stories.
After all, how often do we have a pandemic?
Mike told me about the interview he had earlier Tuesday with a woman he met on the Galloway Creek Trail, which is part of the Ozark Greenways.
The woman's name is Paula. She tells Mike she has had COVID-19 and has given it to several family members. She says: "If I were in charge I would unmask everybody. I know that sounds harsh; I would let people build up their immunities."
Mike Comerford spends much time at public libraries during his bicycle odyssey along Route 66 to Los Angeles. He often posts about his journey while on the road. He lives bare bones and often sleeps in parks and forest preserves and cemeteries.(Photo: Steve Pokin/News-Leader)
He has posted the remarkable interview on YouTube.
"I don't judge people," Mike tells me.
He simply lets them tell their stories and occasionally asks for clarification.
Mike's raw video is then dressed upwith spiffy graphics and music and posted by the University of Florida.
Go to YouTube and search for "thestorycycle and samuel proctor."
Mike has three younger sisters. His father was in the Navy and the family moved 10 times by the time he was 11, when they landed in Chicago.
He graduated in 1977 from St. Viator High School in Arlington Heights where, oddly enough, I once coached the track team for a season after stepping off the journalism career ladder to write a novel.
Mike started on the basketball team there and went on to Marquette, where he majored in political science.
He estimates he has visited close to 100 countries.
He worked at English-language papers in Moscow and Budapest.
More: Pokin Around: Love is never having to say I'm sorry I sank so much into my aging vehicle
He stayed at my house Tuesday night and offered these snippets of conversation:
"I'm sure there were guerillas in the area where I was at in the Philippines ...
"We were on the ZambeziRiveralong the border betweenZambiaandZimbabwe ...
"In Switzerland, I had accidentally run onto a restricted area used by the Swiss Army as a mortar range ..."
And he won the city heavyweight title in Cork, Ireland, where he attended college his junior year. He jabbed with his natural hand, his right, and sent them to sleep with his left.
I have no reason to doubt any of this.
After all, here was Exhibit A, in my living room: a 62-year-old journalist riding an old bicycle the 2,110 miles of Route 66.
But I did ask if he is physically up to the task.
If I take it in small steps," he says. "I am out of shape and older than I should be for such a project."
He takes his time and bikes 30 to 40 miles a day. Regarding his itinerary, he quotes Forrest Gump:
"When I got tired, I slept. When I got hungry, I ate. When I had to go, you know, I went."
In fact, Mike says, he is in the vanguard of what is called "slow journalism."
He asks if I know the exploits of journalist Paul Salopek, a National Geographic Fellow who has won Pulitzer Prizes for reporting on human genetics and the civil war in the Congo.
No, I say.
Salopek is retracing our ancestors' ancient migration on foot out of Africa and across the globe. His 24,000-mile, multiyear-voyagebegan in Ethiopia, believed to be our evolutionary "Eden." He started in January 2013 and his walk will end at the tipof South America.
It is called the "Out of Eden Walk" and Salopek is writing about it for National Geographic.
More: Pokin Around: When Captain Pink and the Larry Flynt circus came to Springfield
Mike has already completed one "slow journalism" project that resulted in his 2020 self-published book "American Oz: An Astonishing Year Inside Traveling Carnivals at State Fairs & Festivals."
Mike Comerford last year self-published "American Oz: An Astonishing Year Inside Traveling Carnivals at State Fairs & Festivals." He spent February 2013 to February 2014 hitchhiking as he worked as a carny from New York to California and Alaska to Mexico.(Photo: Steve Pokin/News-Leader)
From February 2013 to February 2014 he worked as a carny in 10 states from New York to California and up to Alaska.
In the book, which I've read, he captures the behind-the-scenes life of carnies and talks about the new face of American carnival workers who typically are from Mexico and work here on the same type of visa used by farm workers from Mexico.
The most amazing part of the book is Mike's trip to Tlapacoyan, Mexico. He went there during adrug cartel war between El Chapo's Sinaloa drug cartel and the Los Zetas drug cartel.
He had onlythe name of a fellow carny whom he had befriended.
Most men in Tlapacoyan come to the United States to work carnivals during the summer.
Mike took a 1,100-mile bus ride from Dallas to Veracruz, Mexico, which took 33 hours. He rode another bus six hours to Tlapacoyan and, incredibly, found his friend.
The book is available on Amazon.
Mike made some money on "American Oz."
"I know how to sell a book," he says.
He hopes to make some money on his current project.
I am attempting to make a living out of this. I want to be a book writer who writes a lot of books. If I wrote 20 books and all 20 of those books are making $1,000 then I will have a nice income. These are my first two projects.
Did you ever envision these "slow journalism" projects as a career?
"I never had a career vision for myself. I did want to travel and I did want to write.
His first inkling this could be a living came when he was hitchhiking through Canada.
"I met a French journalist in a van doing radio reports back to France. I saw this guy making a living doing whatever he wanted to do. And he was making a living by writing."
Mike is divorced and the love-of-his-life is his 15-year-old daughter Grace. He talks to her every day. She worries about him.
"She tells me not to eat badly. Or get run over by a car. Or get COVID."
At one point, he tells me, she suggested he hop a train to Los Angeles and just pretend like he rode his bicycle there.
On Wednesday morning, it is pouring rain in Springfield.
Mike is in my home packing his gear. He wraps his feet in cellophane to keep them warm. He tells me that not once in his life has ever felt cold in his sleeping bag and tent.
In my driveway, he takes his ancient bicycle from the back of my vehicle.
It thunders; there is lightning; Ron Hearst of KY3 warns of tornadoes.
I worry about Mike and offer him another night in Springfield.
No, he says. Time to get moving. Remember? Slow and steady.
Attached by bungee cordsis a sign on the back of his bicycle: "TELL ME A STORY. THE STORY BICYCLE. Check it on YouTube. TheStoryCycle@GMAIL.COM."
He swings his legonto his bike like John Wayne getting on a horse to face destiny.
Mike Comerford has always been an easy guy to talk to. He says people are more than willing to tell him about the impact of COVID on their lives as he videotapes them. While in Springfield, he interviewed a woman along the Ozarks Greenway who told him why she thinks masks are not needed.(Photo: Steve Pokin/News-Leader)
I say goodbye.
He looks at the ominous sky.
"The Mojave Desert," he says, "nowthat's gonna be tough."
Keep those questions coming. Send themto The Answer Man at 417-836-1253, spokin@gannett.com, on Twitter @stevepokinNL or by mail to 651 Boonville Ave., Springfield, MO 65806.
Read or Share this story: https://www.news-leader.com/story/news/local/ozarks/2021/03/19/pokin-around-visit-old-friend-cycling-mother-road-collect-covid-19-stories-route-66/4740828001/
Visit link:
Pokin Around: A visit from an old friend cycling the Mother Road to collect COVID stories - News-Leader
Posted in Human Genetics
Comments Off on Pokin Around: A visit from an old friend cycling the Mother Road to collect COVID stories – News-Leader
Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report – Business Wire
Posted: at 4:36 pm
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced an interview with CEO Dr. Pnina Fishman will air on The RedChip Money Report on the Bloomberg Network in the U.S. on Saturday, March 20th, at 7 p.m. local time in 73M homes across the United States. The RedChip Money Report also airs on Bloomberg International in Europe in 100M homes at 6 pm local time on Sundays.
In the exclusive interview, Dr. Fishman discusses the Companys upcoming milestones, updates on the pipeline of proprietary small molecule drugs addressing inflammatory, cancer and liver diseases.
To view the interview segment, please visit: https://youtu.be/T6ccv539s4I
The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.
About Piclidenoson
Piclidenoson is a novel, first-in-class, A3 adenosine receptor agonist (A3AR) small molecule, orally bioavailable drug with a favorable therapeutic index demonstrated in Phase II clinical studies. It is currently being evaluated in a multinational Phase III study as a treatment for moderate to severe psoriasis and a Phase II U.S. study for the treatment of moderate to severe COVID-19.
About Namodenoson
Namodenoson is a small orally bioavailable drug that binds with high affinity and selectivity to the A3 adenosine receptor (A3AR). Namodenoson was evaluated in Phase II trials for two indications, as a second line treatment for hepatocellular carcinoma, and as a treatment for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). A3AR is highly expressed in diseased cells whereas low expression is found in normal cells. This differential effect accounts for the excellent safety profile of the drug.
About Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, liver, inflammatory disease and COVID-19. The Company's lead drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis and a Phase II study in the treatment of moderate COVID-19. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the most common form of liver cancer, and successfully achieved its primary endpoint in a Phase II trial for the treatment of non-alcoholic steatohepatitis (NASH). Namodenoson has been granted Orphan Drug Designation in the U.S. and Europe and Fast Track Designation as a second line treatment for HCC by the U.S. Food and Drug Administration. Namodenoson has also shown proof of concept to potentially treat other cancers including colon, prostate, and melanoma. CF602, the Company's third drug candidate, has shown efficacy in the treatment of erectile dysfunction. These drugs have an excellent safety profile with experience in over 1,500 patients in clinical studies to date. For more information please visit: http://www.can-fite.com.
Forward-Looking Statements
This press release may contain forward-looking statements, about Can-Fites expectations, beliefs or intentions regarding, among other things, market risks and uncertainties, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, Can-Fite or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as believe, expect, intend, plan, may, should or anticipate or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by Can-Fite with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of Can-Fites authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause Can-Fites actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause Can-Fites actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: our history of losses and needs for additional capital to fund our operations and our inability to obtain additional capital on acceptable terms, or at all; uncertainties of cash flows and inability to meet working capital needs; the impact of the COVID-19 pandemic; the initiation, timing, progress and results of our preclinical studies, clinical trials and other product candidate development efforts; our ability to advance our product candidates into clinical trials or to successfully complete our preclinical studies or clinical trials; our receipt of regulatory approvals for our product candidates, and the timing of other regulatory filings and approvals; the clinical development, commercialization and market acceptance of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates and our ability to operate our business without infringing the intellectual property rights of others; competitive companies, technologies and our industry; statements as to the impact of the political and security situation in Israel on our business; and risks and other risk factors detailed in Can-Fites filings with the SEC and in its periodic filings with the TASE. In addition, Can-Fite operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. Can-Fite does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise.
Continue reading here:
Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report - Business Wire
Posted in Psoriasis
Comments Off on Can-Fite BioPharma Interview to Air on Bloomberg Television U.S. on the RedChip Money Report – Business Wire
Politically Incorrect Humor – Daily Memes, Jokes …
Posted: March 20, 2021 at 3:19 am
Some may wonder why the axis powers of the media, Big Tech, Big Business, and leftist government officials continue to push indefinite, anti-freedom Covid restrictions. Its all about establishing permanent power and control. Lets look at these one at a time:
Im sure some think Im exaggerating when I say most Covid restrictions will be permanent, but the same thing has been said EVERY step of the way15 days to slow the spread, just a 30-day mask mandate, we have to wait for a vaccine, we dont know about new strains,there will ALWAYS be a new excusewinter seasonal outbreaks, new strains, flu deaths, co-morbid conditions, and on and on. Freedom will NEVER be given back by the Ruling Class. It must be TAKEN BACK! Demand your freedom! Set the standard and show others YOU ARE NOT ALONE!
Fauci Absolutely Torched By Rand Paul About COVID Vaccines, Masks, and Immunity
CNNs Chief Medical Correspondent Tries To Defend Faucis Mask NonsenseEnds Up Peddling More COVID Idiocy
NJ Gov. Phil Murphy Hints That Vaccine Card May be Mandated For Public EventsWeve Officially Become a 1984 Totalitarian Society10 Steps to Prepare for a Biden Presidency12 Lessons Learned from Covid-19Covid-19 Facemasks Meme GalleryDr. Anthony Fauci Meme GalleryMainstream Media Meme Gallery 5Big Tech Fascism Meme Gallery 210 Steps to Get Friends & Family Off of Facebook/Twitter and On To MeWe, Parler, and other Alternative Social Media
View original post here:
Politically Incorrect Humor - Daily Memes, Jokes ...
Posted in Politically Incorrect
Comments Off on Politically Incorrect Humor – Daily Memes, Jokes …
4 men linked to Proud Boys charged in plot to attack Capitol – FOX40
Posted: at 3:19 am
Four men described as leaders of the far-right Proud Boys have been charged in the U.S. Capitol riots, as an indictment ordered unsealed on Friday presents fresh evidence of how federal officials believe group members planned and carried out a coordinated attack to stop Congress from certifying President Joe Bidens electoral victory.
So far, at least 19 leaders, members or associates of the neo-fascist Proud Boyshave been charged in federal courtwith offenses related to the Jan. 6 riots. The latest indictment suggests the Proud Boys deployed a much larger contingent in Washington, with over 60 users participating in an encrypted messaging channel for group members that was created a day before the riots.
The Proud Boys abandoned an earlier channel and created the new Boots on the Ground channel after police arrested the groups top leader, Enrique Tarrio, in Washington. Tarrio was arrested on Jan. 4 and charged with vandalizing a Black Lives Matter banner at a historic Black church during a protest in December. He was ordered to stay out of the District of Columbia.
Tarrio hasnt been charged in connection with the riots, but the latest indictment refers to him by his title as Proud Boys chairman.
Ethan Nordean and Joseph Biggs, two of the four defendants charged in the latest indictment, were arrested several weeks ago on separate but related charges. The new indictment also charges Zachary Rehl and Charles Donohoe.
Nordean, 30, of Auburn, Washington, was a Proud Boys chapter president and member of the groups national Elders Council. Biggs, 37, of Ormond Beach, Florida, is a self-described Proud Boys organizer. Rehl, 35, of Philadelphia, and Donohoe, 33, of North Carolina, serve as presidents of their local Proud Boys chapters, according to the indictment.
Attorneys for the four men didnt immediately respond to messages seeking comment Friday.
Proud Boys members, who describe themselves as a politically incorrect mens club for Western chauvinists, have frequently engaged in street fights with antifascist activists at rallies and protests. Vice Media co-founder Gavin McInnes, who founded the Proud Boys in 2016, sued the Southern Poverty Law Center for labeling it as a hate group.
The Proud Boys met at the Washington Monument around 10 a.m. on Jan. 6 and marched to the Capitol before then-President Donald Trump finished addressing thousands of supporters near the White House.
Around two hours later, just before Congress convened a joint session to certify the election results, a group of Proud Boys followed a crowd of people who breached barriers at a pedestrian entrance to the Capitol grounds, the indictment says. Several Proud Boys also entered the Capitol building itself after the mob smashed windows and forced open doors.
At 3:38 p.m., Donohoe announced on the Boots on the Ground channel that he and others were regrouping with a second force as some rioters began to leave the Capitol, according to the indictment.
This was not simply a march. This was an incredible attack on our institutions of government, Assistant U.S. Attorney Jason McCullough said during a recent hearing for Nordeans case.
Prosecutors have said the Proud Boys arranged for members to communicate using specific frequencies on Baofeng radios. The Chinese-made devices can be programmed for use on hundreds of frequencies, making them difficult for outsiders to eavesdrop.
After Tarrios arrest, Donohoe expressed concern that their encrypted communications could be compromised when police searched the group chairmans phone, according to the new indictment. In a Jan. 4 post on a newly created channel, Donohoe warned members that they could be looking at Gang charges and wrote, Stop everything immediately, the indictment says.
This comes from the top, he added.
A day before the riots, Biggs posted on the Boots on the Ground channel that the group had a plan for the night before and the day of the riots, according to the indictment.
In Nordeans case, a federal judge accused prosecutors of backtracking on their claims that he instructed Proud Boys members to split up into smaller groups and directed a strategic plan to breach the Capitol.
Thats a far cry from what I heard at the hearing today, U.S. District Judge Beryl Howell said on March 3.
Howell concluded that Nordean was extensively involved in pre-planning for the events of Jan. 6 and that he and other Proud Boys were clearly prepared for a violent confrontation that day. However, she said evidence that Nordean directed other Proud Boys members to break into the building is weak to say the least and ordered him freed from jail before trial.
Originally posted here:
4 men linked to Proud Boys charged in plot to attack Capitol - FOX40
Posted in Politically Incorrect
Comments Off on 4 men linked to Proud Boys charged in plot to attack Capitol – FOX40
Mary Ann Crum: Who will they cancel next? – Index-Journal
Posted: at 3:19 am
I recently saw a picture that captured so well at least one slice of the crazy pie being served up to us these days. The graphic showed Mr. Potato Head looking side-eyed at a Mr. Coffee coffeemaker and saying, Youre next.
As youve probably heard, Mr. Potato Head, the classic childrens toy, is being rebranded as simply Potato Head because gender-related titles such as Mr. have been deemed politically incorrect and taboo. (Im rolling my eyes as hard as theyll possibly roll.)
Aunt Jemima, Uncle Ben (the rice guy) and some Dr. Seuss books have also recently been sacrificed upon the altar of political correctness, and warnings have been added to some classic Disney movies and Muppet videos because it was suddenly decided they might offend the easily offended.
This is just nuts. Our culture has fallen so quickly and far down the bottomless pit of censorship and political correctness that I wonder if well ever be able to climb back out again. Its hard to watch the United States devolve into something that bears so little resemblance to the free republic it was founded to be.
Mr. Potato Head? Dr. Seuss? Kermit the Frog? Aunt Jemima? Dumbo? Dont we have bigger battles to fight?
Although the current rush to frivolously cancel people, products, books, fictional characters, history, movies and free speech is dangerous and disturbing, this kind of madness is something we Christians should actually be accustomed to. Individuals, institutions and governments have, after all, been trying to cancel God, His Word and His people since the Garden of Eden.
Here are just a few examples:
When Adam and Eve disobeyed the one prohibitive law God had given them, they were essentially canceling the personal, warm relationship God desired to have with them.
Enemies of the Jewish people and the nation of Israel have been trying to cancel them ever since God first promised to form a great nation from Abrahams descendants.
Jewish and Roman leaders tried to cancel Jesus by crucifying Him. They then spread a whopper of a lie in an attempt to cancel the miracle of Christs resurrection.
Early Christ-followers were constantly threatened with cancellation just about everywhere a church was formed. Sadly, that kind of severe persecution continues in some places today.
Evil perpetrated by those claiming to be Christians from the Spanish Inquisition to greed and sexual immorality within the church has distorted the Gospel and tragically caused many to personally reject, or cancel, it.
Christians are typically portrayed in the media as bumbling, judgmental, delusional, hypocritical, unpleasant, or irrelevant. Is this an attempt to cancel Christianity or are scriptwriters simply unaware that the majority of true believers, though certainly imperfect, are actually nice, intelligent people?
Changing the names of a few products might not matter much, but the spirit of offense sweeping through our world does because its irrationality and deception is leading to more and more censorship and persecution of those who express their faith in Jesus Christ.
Two thousand years ago, Jesus said, ... blessed is the one who is not offended by me (Matthew 11:6). Anyone offended by Mr. Potato Head and Aunt Jemima is likely going to find it hard to tolerate Jesus, the one who dares to claim, I am the way, and the truth, and the life; no one comes to the Father except through Me (John 14:6).
If they despise Jesus, what will they do with those of us who worship Him? Jesus answered that: If the world hates you, know that it has hated Me before it hated you John 15:18.
What should our response be? Love.
Why? We love because He first loved us (1 John 4:19).
God had every right to cancel us, but He didnt. Lord, help us to love like that.
See more here:
Mary Ann Crum: Who will they cancel next? - Index-Journal
Posted in Politically Incorrect
Comments Off on Mary Ann Crum: Who will they cancel next? – Index-Journal
Pushing Mandates And Fear While Suppressing Self-Help And Strength In The Coronavirus Panic – OpEd – Eurasia Review
Posted: at 3:03 am
There are plenty of things people can do on their own to protect themselves from coronavirus, as well as many other health threats. Self-help has long been one of the most important avenues to enhancing health and countering illness. It works fine without the need to rely on any government edicts such as stay at home orders, business shutdown and capacity limit orders, social distancing and mask mandates, and vaccine passport requirements.
Politicians, bureaucrats, and big money media people have repeatedly pushed a different course over the last year, telling people over and over during the coronavirus panic to wear a mask, keep six feet distance, stay home, and take the vaccine. These demands all fall in line with increasing government power at the expense of freedom and, especially in the case of vaccines, pursuing huge government spending programs that benefits powerful special interests.
In contrast, we hardly ever hear politicians, bureaucrats, and big money media saying we should take vitamins, eat healthier foods, lose weight, or get enough sleep. Why not? All these actions can help people improve their health, including by strengthening their immune systems ability to protect them from coronavirus. As a bonus, a person with improved health and immune system will be in a better position to fend off other diseases and to enjoy life more fully.
Maybe the reason government and big money media tend to keep mum about such self-help health actions is that people will be less susceptible to fearmongering and more adverse to freedom-crushing mandates supposedly purposed to advance public health if they know they can take actions on their own to deal with coronavirus and other health threats.
Still, wishing for government to step in as a health self-help advocate is a wish we would likely regret if we could foresee its fruition. Thescenein the movie 1984 in which a dominating exercise coach appears on Winston Smiths home telescreen and hectors him through morning exercises comes to mind when I think about what government would do given the task of helping us improve our health and immune systems. Better to keep government out altogether. The tendency toward tyranny is too hard to resist.
One of the most prolific and informative communicators about actions people can take to enhance their health and counter various ailments is Joseph Mercola. Mercola, who is a doctor, has over the last year given much of his attention to advising people regarding how they can prepare their bodies to resist sickness from coronavirus, as well as how they can take actions to counter a coronavirus infection. Mercola has presented this information through many articles and hisStop Covid Coldwebsite.
But, Mercola, a champion of enhancing health and suppressing coronavirus, is not welcomed and promoted by the coronavirus crackdown proponents in government and big money media. They dont like that he stand upfor freedomand in opposition to authoritarian tactics such aslockdowns,mask mandates, andvaccine passportsimposed in the name of countering coronavirus. Mercola has also beenchallenging head-onthe new dominant push of the crackdown proponents that everyone should take the experimental coronavirus vaccines, which Mercolaexplainsare not even really vaccines under the normal meaning of the term.
The fearmongers in government and media are also not so keen on Mercolas message in favor of personal empowerment. Mercola has not been repeating the message that people should hide in their homes and behind masks, while shunning normal personal interactions. Mercola has been, instead, a voice for people taking charge of their own actions and of their own health. You can take actions to protect yourself against coronavirus and other health threats is his message. Mercola dares to declare that people should not live in dire fear of coronavirus that is not even a major health threat to most people.
More brave, informed people is bad news for the coronavirus crackdown and those who profit from it.
Mercola is a threat to the newly emerged yet already large coronavirus-industrial complex that extends through areas including pharmaceuticals, medical testing, masks, media, surveillance, and law enforcement. Thus, it should be little surprise that there is an effort to silence him. Indeed, the effort against Mercola is quite strong as he explains in three recent articlesFDA Warns Dr. Mercola to Stop Writing About Vitamin D, The Web of Elite Extremists Behind Censorship of Mercola, and Top Dr. Mercola Videos Banned by Google.
The attack on Mercolas ability to communicate is yet another example of the great danger from the coronavirus crackdown. Free speech and the information people desire to aid them in advancing their own health and happiness are being targeted for destruction by people seeking to impose a dystopian new normal on us under a health-promotion pretext. Mercolas plight is a clear demonstration of the aphorism libertarian communicator Ron Paul mentions on occasion: Truth is treason in an empire of lies.
This article was published by RonPaul Institute.
Here is the original post:
Pushing Mandates And Fear While Suppressing Self-Help And Strength In The Coronavirus Panic - OpEd - Eurasia Review
Posted in Ron Paul
Comments Off on Pushing Mandates And Fear While Suppressing Self-Help And Strength In The Coronavirus Panic – OpEd – Eurasia Review
A towering genome: Experimentally validated adaptations to high blood pressure and extreme stature in the giraffe – Science Advances
Posted: at 2:57 am
INTRODUCTION
Giraffes are immediately recognizable due to their exceptionally long necks and legs, making them the tallest terrestrial animals. Giraffes played a central role in different evolutionary schools of thought, including those of Lamarck and Darwin. Their unusual anatomy is thought to provide various selective advantages. In addition to allowing access to otherwise inaccessible food resources (1), their elevated head position provides an excellent vantage point for scanning the horizon and thus detecting predators or competitors, both of which are crucial for their survival (2). However, their exceptional anatomy is also accompanied by considerable physiological challenges. Most notably, the cardiovascular system has to tolerate twofold higher systemic blood pressure than most other mammals to supply the brain with blood (3). This elevated hydrostatic pressure has resulted in hypertrophy of their cardiac and arteriole walls (3) and adaptations of the circulation system that prevent sudden changes in blood pressure when a giraffe elevates or lowers its head (4). Giraffes also have neuromotor delays due to their long neural networks (5) and face difficulties in rising due to their long legs, which increases the danger associated with resting and drinking. They also require greatly enlarged and strengthened nuchal ligaments to support their long, heavy neck (6). Hence, the giraffe provides a unique case for studying co-adaptation or evolution in several different traits that are causally linked to an extreme body plan.
The okapi (Okapia johnstoni) is the only other extant member of the Giraffidae family and provides a useful point of genomic comparison. A study published in 2016 provided the first giraffe and okapi draft genomes and identified candidate genes and pathways involved in neck elongation and cardiovascular adaptations (7). However, these initial draft genomes were relatively fragmented, which can both introduce certain biases and limit the interpretation of some analyses (8). Furthermore, the comparative analyses carried out using these draft genomes were restricted to 17,210 genes, which were annotated by aligning with cattle (Bos taurus) reference transcripts, thus limiting the resolution power to explore genomic features unique to the giraffe, not least given the paucity of other ruminant genomes available at that time. Hence, the availability of a higher-quality giraffe genome assembly together with our recently published whole-genome dataset for ~50 ruminant species (9) opens up the possibility of identifying giraffe-specific mutations with a much higher accuracy and robustness. This, in turn, provides a better resource for inferring the true genomic changes that account for the unique body plan of the giraffe.
Here, we report an improved, chromosome-level genome assembly of a Rothschilds giraffe (Giraffa camelopardalis rothschildi), the results of comparative analysis against the recently available ruminant genomes, andcruciallyfunctional validation of one key cardiovascular and skeletal gene in gene-edited mice. These results provide insights into the genetic basis of the giraffe anatomy and associated adaptations, with particular implications concerning the cardiovascular system, which may be helpful for treating human cardiovascular disease and hypertension.
We sequenced the genome of a male Rothschilds giraffe with a combination of single-molecule real-time sequencing (using an Oxford Nanopore platform), paired-end sequencing (with an Illumina HiSeq 2000 system), and Hi-C sequencing (figs. S1 and S2 and table S1). First, we used Nanopore data to generate initial contigs, and after polishing with Illumina reads, we obtained an assembly with contig N50 of 35.9 Mb (table S2). Next, Hi-C data were used to anchor the contigs into chromosomes, which yielded a final assembly of 2.44 Gb with ~97.95% of the bases successfully anchored to 15 chromosomes (2n = 30) (figs. S3 and S4 and table S3). A series of evaluations show that the genome assembly is of high quality (see the Supplementary Materials, figs. S2 to S6, and tables S4 to S11).
Chromosome evolution is related to genome size, gene family evolution, and speciation (10). The giraffe has many fewer chromosomes (2n = 30) than the putative ancestral karyotype of even-toed ungulates (2n = 58 to 60), suggesting the occurrence of multiple chromosome fusion events in its evolution (11). Using the genomes of cattle, goat, giraffe, and okapi, with sperm whale as outgroup, we reconstructed the ancestral karyotype of the Giraffidae and Bovidae families (2n = 60) (table S12), which corresponds to the ancestor of the Pecora suborder (11). The results indicate that just three fissions and three fusions occurred in the cattle lineage since the pecoran ancestor. Hence, most of the ancestral chromosome structure is retained in cattle, including the complement of 30 chromosomes. In contrast, a minimum of four fissions and 17 fusions occurred between the pecoran ancestor and the giraffe, resulting in a substantial decrease (to 15) in haploid chromosome number (Fig. 1). The functional significanceif anyof such prolific chromosome fusions in giraffes requires further research.
(A) The figure displays the distribution of ancestral chromosome segments in cattle and giraffe genomes, including interchromosome rearrangements and fission and fusion events in cattle and giraffe. Blue asterisks in the cattle chromosome diagram indicate chromosome fission events in cattle. Blue asterisks in the giraffe chromosome diagram indicate sites of chromosome rearrangements. (B) Circos plot showing syntenic relationships of chromosomes between giraffe (left) and cattle (right). Chromosomes are colored on the basis of the cattle homologies. (C) Two types of collinear relationship between giraffe and cattle. The top and bottom horizontal lines represent giraffe and cattle chromosomes, respectively, and the lines between them link the alignment blocks.
We next evaluated the adaptive divergence between giraffe and other mammals in coding regions, using both the branch and the branch-site models implemented in PAML (12). We detected 101 positively selected genes (PSGs) and 359 rapidly evolving genes (REGs) in the giraffe (P < 0.05 according to 2 tests in both cases) (fig. S7 and tables S13 and S14) (13). This is a large increase compared to those found in the previous giraffe genome study, which identified 17 PSGs and 53 genes with adaptive divergence (high divergence compared with other mammals or unique substitutions) in giraffe (7). Notably, while 7 of the 17 PSGs from the previous study overlapped with our findings, the remaining 10 PSGs showed no positive selection signal in our analyses, which is primarily caused by the inclusion of many more ruminant branches as background. We show two examples of how the inclusion of a larger background panel or better genome quality refined our ability to identify giraffe-specific selection signals (fig. S8). Similarly, only 15 of the 53 previously identified adaptive divergence genes (7) were identified as PSGs or REGs in our analysis. Together, the improved genome assembly (better genome completeness, accuracy, and annotation) and higher number of accessible ruminant reference genomes allow us to substantially decrease both false positive and false negative signals of genes undergoing adaptive evolution in the giraffe. A Gene Ontology (GO) enrichment analysis showed that the 460 PSGs and REGs identified in the present study are primarily related to growth and development, nervous and visual systems, circadian rhythm, and blood pressure regulation (table S15). The KEGG (Kyoto Encyclopedia of Genes and Genomes) pathwaybased analysis suggested that the rapidly evolving pathways in giraffe compared to okapi are related to metabolic, circulatory, and immune systems (table S16).
The giraffe fibroblast growth factor (FGF) receptorlike protein 1 (FGFRL1) gene has previously been identified as one of the most conspicuous targets of selection in the giraffe (7). FGFRL1 contains a cluster of seven nonsynonymous mutations in its key FGF binding domain when compared against sequences in other ruminants and outgroup mammals (fig. S9). Using our substantially expanded set of background genomes, we confirmed that these mutations are unique to the giraffe and that FGFRL1 contains more unique substitutions than any other giraffe gene (table S17). Mutations in FGFRL1 cause severe cardiovascular and skeletal defects in humans and mice (14, 15), and hence we follow Agaba et al. (7) in hypothesizing that FGFRL1 may be associated with the extreme cardiovascular and skeletal adaptations in the giraffe. To investigate the in vivo consequences of these substitutions, we introduced these seven mutations into the FGFRL1 gene of mice to obtain giraffe-type FGFRL1 mice, using CRISPR-Cas9 technology (fig. S10). In contrast to mice with targeted complete deletion of the gene (14), which die with multiple congenital malformations, giraffe-type FGFRL1 mice were viable and fertile.
The cardiovascular hemodynamic in the giraffe is characterized by exceptionally high blood pressure without related organ damage, in contrast to the typical detrimental effects of hypertension observed in other animals/humans (3). FGFRL1 is known to be involved in the cardiovascular system (14), and we hypothesized that some vascular adaptations in the giraffe may only be apparent in a hypertensive physiological setting. To test this, we induced high blood pressure in wild-type (WT) and mutant FGFRL1 mice. The mice were infused with angiotensin II (Ang II; 900 ng/kg per minute; fig. S11), which induces hypertension by vasoconstriction and sodium retention. Our giraffe-type FGFRL1 mice showed no signs of congenital heart defects (fig. S12) or any obvious alterations in heart rate compared to WT controls (fig. S13). Although the basal blood pressure was slightly higher in giraffe-type than in WT FGFRL1 mice, no significant difference was observed (fig. S13). After Ang II infusion for 28 days, the average systolic and diastolic blood pressure in WT controls were significantly increased to 158.97 5.01 and 94.54 8.60 mmHg (Fig. 2A), respectively, confirming that hypertension was successfully induced in them. Unexpectedly, the Ang IIinduced hypertension was absent in giraffe-type FGFRL1 mice, which showed average systolic and diastolic pressures of 125.30 5.97 and 83.43 11.77 mmHg, respectively, after Ang II infusion for 28 days (Fig. 2A), not significantly different from giraffe-type FGFRL1 controls. Moreover, significantly less myocardial and renal fibrosis was observed in giraffe-type FGFRL1 mice, as manifested by significantly lower proportion of collagen fibers in their heart and kidney than in WT controls, which obviously resulted from the absence of Ang IIinduced hypertension in giraffe-type FGFRL1 mice (Fig. 2B and fig. S14). In addition, the impaired heart function caused by hypertension in Ang IItreated WT mice was also significantly alleviated in giraffe-type FGFRL1 mice, as evidenced by improved left ventricular ejection fractions (LVEFs) and fractional shortening (LVFS) (fig. S15). Our findings collectively suggest that the giraffe-type FGFRL1 has little effect on cardiac development but can prevent Ang IIinduced hypertension and thus avoid or at least alleviate a range of detrimental effects of hypertension. In addition, our molecular dynamics (MD) simulations suggested that the unique variants in giraffe-type FGFRL1 could affect its binding affinity with FGF ligands (fig. S16), potentially interfering with their cross-talk with renin-angiotensin-aldosterone system to modulate blood pressure and providing a possible mechanism by which giraffe-type FGFRL1 modulates blood pressure (16). Despite the differences in cardiovascular structure and physiology between mice and human and the possibility that other genes may have contributed to the observed systemic co-adaptation to hypertension, it is intriguing to speculate that FGFRL1 might hold promise as a therapeutic target for prevention or treatment of hypertension or cardiovascular diseases in humans. Nevertheless, we acknowledge that this perspective is tentative and awaits a thorough investigation of the mechanisms behind the observed cardiovascular effect of giraffe-type FGFRL1.
(A) Giraffe-type FGFRL1 mice showed significantly lower systolic, diastolic, and mean arterial pressures (mmHg) than WT FGFRL1 mice after Ang II infusion for 28 days. *P < 0.05, **P < 0.01, ***P < 0.001, one-way ANOVA followed by Tukeys post hoc test. (B) Giraffe-type FGFRL1 mice had significantly lower proportions of fibrotic areas in heart than WT FGFRL1 mice after 28 days of Ang II infusion. ***P < 0.001, one-way ANOVA followed by Tukeys post hoc test. Error bars indicate SD. (C) Whole-mount skeletons of P0 mice showed hypoplasia of skeletal elements in giraffe-type FGFRL1 mice. **P < 0.01 by t test. (D) Adult giraffe-type FGFRL1 mice show no discernible body size and skeletal phenotype difference to WT mice. (E) Giraffe-type FGFRL1 mice showed significantly higher BMD, BV/TV, and average trabeculae thickness than WT mice. *P < 0.05, **P < 0.01 by t test. Photo credit: Jianbo Gao, The Fourth Military Medical University.
In addition to the observed cardiovascular effect, we noticed that postnatal day 0 (P0) giraffe-type FGFRL1 mice showed prenatal hypoplasia of skeletal elements, with a smaller body size, delayed craniofacial development, shortened axial/appendicular skeletons, and smaller vertebral lengths than the P0 WT mice (Fig. 2C and fig. S17). In contrast, adult giraffe-type FGFRL1 mice (24 to 26 g, 16 weeks) showed no discernible skeletal phenotype compared with WT mice or any significant deviation in body size and weight, limb length, or vertebral height (Fig. 2D and fig. S18). This suggests that mutations in this gene in itself are not sufficient for neck elongation in the giraffe, refuting a previous hypothesis (7), although again we must recognize the limitations of introducing a gene into a different genetic background. However, it also shows that giraffe-type FGFRL1-associated postnatal bone growth can compensate for the observed prenatal effects such that FGFRL1 may play an indirect role in the exceptional bone growth of giraffe, e.g., by accelerating bone formation to maintain bone mineral density (BMD), as in humans (17). Therefore, we next examined bone ultrastructure by micro computed tomography (microCT). Giraffe-type FGFRL1 mice achieved significantly higher BMD, bone volume/total volume (BV/TV) ratio, and average trabeculae thickness in vertebrae (C3) and distal femur (Fig. 2E and fig. S19). Skeletal growth rate tends to be inversely related to bone strength in animals (18), but despite having the highest skeletal growth rate among mammals, giraffes maintain normal BMD (19). In summary, we find indications for a pleiotropic adaptive effect of the highly unique giraffe-type FGFRL1 by not only significantly enhancing hypertension resistance but also achieving normal bone strength, despite the accelerated rate of bone growth in the giraffe.
Previous anatomical and physiological analyses suggest that multiple giraffe organs are involved in associated adaptations of the cardiovascular system, including hypertrophy of the left ventricle and interventricular walls (3), thickening of blood vessels of the lower extremities, and low glomerular filtration rates (20). Our results revealed that several pathways involving tissues influenced by high blood pressure, such as blood vessels, heart, and kidney, were significantly diverged between giraffe and other ruminants (table S16). The platelet activation pathway plays an important role in hypertension-associated thrombosis (Fig. 3A) (21). Three REGs (COL1A2, LYN, and PLCB1) and a number of genes with giraffe-specific amino acid variations are involved in the two major platelet activation, shape change, and platelet aggregation paths. A further set of PSGs and REGs that participate in phosphatidylinositol metabolism (PIP4K2A, ISYNA1, MTMR3, CDS1, and INPP1) may also be involved in the regulation of platelet activation (22). Another giraffe-divergent pathway is the adrenergic signaling pathway in cardiomyocytes, which is related to cardiac contraction and possibly the morphological remodeling of the giraffe heart (Fig. 3B) (23). Highly divergent genes in this pathway are mainly involved in ion transport (SCN7A, SLC9A1, ATP1A4, and CACNA2D4), which is important for myocardial function (24). We also found strong signals of adaptation in two major adrenergic receptors (ADRA1A and ADRA2B), as previously reported (7). Although ADRA2B is mainly expressed in the nervous system, both of these receptors are strongly related to blood pressure regulation (25, 26). Last, we detected strong giraffe-specific divergence in genes related to the proximal tubule bicarbonate reclamation and endocrine and other factor-regulated calcium reabsorption pathways. Changes in these pathways may reduce the pressure gradient across membranes in the giraffe kidney and protect it from hypertensive damage (Fig. 3C) (20). The REG AQP1 encodes a water-transporting protein in cell membranes of kidney proximal tubules and is involved in kidney development and injury responses (27). Two REGs (PLCB1 and ATP1A4) that are reportedly involved in hypertension or related organ damage participate in more than one of the mentioned pathways (28, 29), in accordance with expectations of co-adaptation of the blood vesselheartkidney axis in giraffe. In addition to genes in the mentioned pathways, we also detected other PSGs and REGs that may help to avoid hypertensive damage, including ANGPTL1, which is associated with the integrity of vascular endothelium (30), and TGFB1, which is strongly implicated in multiorgan fibrosis associated with hypertension (31). The finding of multiple genes involved in several phenotypic traits that share evolutionary constraints due to the extreme stature of the giraffe suggests that pleiotropy may play an important role in evolving such an extreme body plan.
(A) Modifications of genes in the platelet activation pathway may help to prevent damage to giraffe blood vessels. (B) Genes in the adrenergic signaling in cardiomyocytes that show high divergence in giraffe. (C) The proximal tubule bicarbonate reclamation (top) and endocrine and other factor-regulated calcium reabsorption (bottom) pathways may help to prevent kidney damage.
For herbivorous ungulates subject to predation, vigilance is crucial for survival and has two components: gathering information and instigating muscular action after signal transduction through the nervous system (32). Giraffes are thought to have a distinctive retinal cone topography that provides the best visual acuity in the Artiodactyla, which, together with the elevated head, enhances the capacity for horizon scanning (33). Accordingly, we found not only a number of PSGs and REGs that contribute to eye development and vision but also a number of genes that are related to Usher syndrome in humans (CDH23, PCDH15, USH2A, NINL, and UBR3), which affects vision, hearing, and balance (34), suggesting a related suite of sensory co-adaptations in giraffe (Fig. 4A). Similar to all other ruminants, we found only two opsin genes; thus, we could not verify that giraffes see color, at least not trichromatic color as has been hypothesized before (35). We found indications that the sense of smell in the giraffe may be degenerated. Compared to okapi, giraffe has lost at least 53 olfactory-related genes, including 50 encoding olfactory receptors, two encoding vomeronasal receptors, and one encoding an odorant binding protein (table S18). Further analysis shows that most of these olfactory receptors are spatially clustered and were lost because of a segmental deletion (Fig. 4B and figs. S20 and S21). Moreover, the contracted gene families in giraffe were also enriched in olfactory receptor activity (fig. S22 and tables S19 and S20). This may be an evolutionary consequence of enhanced vision, consistent with the hypothesized trade-off in sensory acuity found in many taxa (36) and/or with reduction in competition for food with other browsers.
(A) PSGs and REGs associated with giraffes visual, auditory, and balance systems. (B) Giraffes have lost several olfactory receptors (for example, on chromosome 10 of goat) compared to okapi. The location of genes on goat chromosome is shown in the rectangle, and the collinear relationship of giraffe-goat and okapi-goat is shown in the top and bottom panels, respectively. (C) Genetic changes involved in light-mediated regulation of the molecular clock in giraffe suprachiasmatic nucleus (SCN) neurons.
Moreover, the extreme morphology of the giraffe increases its vulnerability when asleep by increasing the time required to become upright. Expectedly, therefore, given their needs for vigilance and high food intakes, giraffe sleep durations are among the lowest recorded (37). Concordantly, we found evidence of rapid evolution of PER1 in giraffe, a period family gene critical for the maintenance of circadian rhythm (38) and the emergence of a stop codon in the first exon of PER2 (Fig. 4C and fig. S23), possibly altering the transcript of this important circadian rhythm gene. HCRT, which plays a role in the regulation of sleep and arousal (39), also shows accelerated evolution in giraffe. Together, there is evidence that adaptive modifications of circadian rhythm and sleep arousal systems in giraffe have promoted short and fragmented sleep patterns. Overall, the comparative genomic analysis highlights that the unique stature of the giraffe has led to a series of necessary behavioral co-adaptations.
Procedures applied in sample collection and animal experiments were reviewed and approved by the Institutional Ethics Committee of the Northwestern Polytechnical University and Fourth Military Medical University. Fresh blood samples of a male Rothschilds giraffe used for genome sequencing were acquired during a routine physical examination at the Guangzhou Zoo in China. High-quality genomic DNA was extracted using a Qiagen DNA purification kit, then used to construct libraries, and sequenced with Illumina HiSeq and Oxford Nanopore GridIOn platforms. Data (199.64 and 140.56 Gb) were obtained, after filtering, from these platforms. In addition, lymphocytes collected from the same blood sample were used for Hi-C library construction, and 138.71-Gb data were obtained using the Illumina HiSeq X Ten platform.
Contigs were assembled by Wtdbg software (v1.2.8) (41), and the assembled contig-level genomes were polished by Racon (v1.2.1) (42) and Pilon (v1.22) (43). Last, the contigs were anchored into chromosomes by Hi-C sequencing reads through the Juicer (version 1.5) (44) and 3D-DNA (version 180922) (45) software workflow. To further improve the chromosome-scale assembly, it was subjected to manual review and refinement using Juicebox Assembly Tools (https://github.com/theaidenlab/juicebox). Last, genome quality was estimated with BUSCO (version 3.0.2) (46), whole-genome synteny with cattle (UMD3.1) genome, and k-mer analysis and by mapping back the initial reads to the assembly.
According to the good genome synteny with cattle genome (Fig. 1B), we assigned the chromosome numbers of our assembly as indicated by previous research (11). Our assembly agrees with the giraffe karyotype revealed before: 13 biarmed autosomal pairs and an acrocentric autosomal pair plus the sex chromosomes (47). Then, we mapped both the Nanopore reads and Illumina reads used for the assembly back onto it. More than 98% of the Nanopore raw reads could be mapped to the assembly properly with an average depth of 54, and 99.99% of genome has a reads depth more than 50, with chromosome X excluded (fig. S5 and table S4). Furthermore, 97.14% of the Illumina reads could be mapped to the genome properly with an average depth of 79 (fig. S5 and table S5). Last, the assembly also recovered 96.15% of the expected single-copy orthologous genes according to BUSCO analysis (table S6), the highest coverage yet for the reported Giraffidae genomes (table S7).
Tandem repeats were predicted by Tandem Repeats Finder software (v4.04) (48). RepeatMasker (open-4.0.7) (49), RepeatModeler (v1.0.8) (49), and RepeatProteinMask (v1.0.8) were used together to predict transposable elements. Gene structures were determined by combining ab initio and homology methods. For ab initio annotation, we used Augustus (v3.2.1) (50) and GENSCAN (v1.0) (51) to analyze the repeat-masked genome. For homolog-based annotation, protein sequences of cattle (B. taurus; ensemble 87 release), sheep (Ovis aries; ensemble 87 release), and human (Homo sapiens; ensemble 87 release) genomes were aligned to giraffe sequences using BLAST software (v2.3.0) (52) and GeneWise (v2.4.1) (53). Then, results from the three methods were integrated by EVidenceModeler software (v1.1.1) (54). To annotate the gene functions, the integrated gene set was aligned against public databases, including KEGG, Swiss-Prot, TrEMBL, COG, and NR with BLAST (v2.3.0) (52), and merged with annotations by InterProScan (v4.8) (55) software. The integrity of annotation was estimated by comparison with reference genome annotations and BUSCO (version 3.0.2) (46). On the basis of homology and ab initio gene prediction, we annotated 21,580 protein-coding genes in the genome (fig. S6 and tables S8 to S11), with 96.81% completeness according to BUSCO analysis, suggesting that our annotation also has high quality (table S6).
The complete mitochondrial cytochrome b (Cytb) gene (1140 base pairs) was used to investigate the phylogenetic status of our sample. In addition, previously published cytb sequences of 160 giraffes and outgroup (okapi and pronghorn) were retrieved from the National Center for Biotechnology Information (NCBI) according to the accession number provided by a research before (56). These sequences were aligned with our data using ClustalW in MEGA7 (57) with default parameters and subsequently adjusted manually to maximize positional homology. Last, the remaining sequences were used to infer the phylogenetic tree using IQ-TREE (58) under parameters -nt AUTO -m MFP -bb 1000 -bnni -o Pronghorn. As a result, the specimen used for genome sequencing was clustered together with the giraffe subspecies Rothschilds giraffe (G. camelopardalis rothschildi) with high support (ultra fast bootstrap value = 93).
We reconstructed the ancestral chromosome karyotype of Giraffidae and Bovidae families using the genomes of cattle, goat, giraffe, okapi, and sperm whale (as outgroup). With giraffe as the reference genome, we carried out pairwise alignments with other species as target using LASTZ (v1.1) with parameters T=2 C=2 H=2000 Y=3400 L=6000 K=2200 --format=axt. Then, axtChain, chainMergeSort, chainPreNet, and ChainNet were used to generate chain and net files as input for DESCHRAMBLER (59). Last, we identified 1502 conserved segments by DESCHRAMBLER at a 300-kb resolution and reconstructed 30 predicted ancestral chromosomes (2n = 60) with a total length of ~2.25 Gb.
To minimize effects of annotation, pseudogenes, and genome quality, we used conserved genome synteny methodology to establish a high-confidence orthologous gene set that included four nonruminants (human, dog, horse, and pig) and six ruminants (pronghorn, giraffe, okapi, forest musk deer, reindeer, and cattle). Using the goat genome sequence (ARS1) as a reference, we performed synteny alignment for these ten species with Last (version 894) (60) and generated pairwise whole-genome alignments with Multiz (version 11.2) (61) using the default parameters. A total of 13,776 genes were extracted from the synteny alignments. We used the Codeml program in the PAML package (version 4.8) (12) to estimate the lineage-specific evolutionary rate for each branch with the phylogenetic extracted from a ruminant study before (9). First, the branch-site model was used for detecting PSGs. The giraffe lineage was specified as the foreground branch, and a likelihood ratio test (LRT) was conducted to examine whether the branch-site model containing positively selected codons (omega > 1) fits better than the null model, which only includes neutral selection or negative selection (omega 1). The P values for model comparison were computed based on chi-square statistics. Besides, the potential positive selection of codon sites was assessed by their posterior probabilities calculated with the Bayes empirical Bayes (BEB) method. The genes with an LRT P < 0.05 and with the sites with a posterior probability of positive selection over 0.95 from the BEB method were treated as PSGs. Then, the branch model that was used for detecting REGs used the same orthologous genes as above. We tested whether the foreground branch (the giraffe lineage) exhibited a significantly higher omega (regardless of whether it is greater than 1) than the background branch (the other lineages) using the LRT test. The genes with an LRT P < 0.05 were treated as REGs in giraffe. The combined set of PSGs and REGs was subjected to KEGG and GO enrichment analysis (P < 0.05) with the online tool Metascape (v1.0) (62).
We used 12 species to construct gene families, including human, horse, dog, pig, killer whale, camel, pronghorn, giraffe, okapi, white-lipped deer, forest musk deer, and cattle. Proteins with premature stop codons, nontriplet codon lengths, and fewer than 30 amino acids were removed. Last, we used OrthoMCL (v2.0.9) (63) for protein clustering with a dataset of 256,596 protein sequences. Family expansion or contraction analysis was performed by CAFE (v3.1) (64), and the phylogenetic tree was extracted from the ruminant study before (9). Gene expansion and contraction results for each branch of the phylogenetic tree were estimated, and enrichment analysis about the gene families expanded or contracted in giraffe was performed with KOBAS (v3.0) (65).
For each KEGG pathway with more than 20 genes, we counted numbers of nonsynonymous and synonymous mutations between giraffe and its most recent common ancestor (Nh and Sh, respectively). We also counted numbers of nonsynonymous mutations and synonymous mutations between okapi and the MCRA (Nt and St, respectively). We formulated a null hypothesis that the probabilities of nonsynonymous mutations compare to synonymous mutations in giraffe and okapi are similar and then applied a one-sided binomial test to identify rapidly evolving pathways with significantly more nonsynonymous mutations than expected. The binomial test included three parameters for each KEGG pathway: the number of successes (Nh), the number of trials (Nh + Sh), and the hypothetical probability of success is given by Nt*All_NhAll_NtNt*All_NhAll_Nt+St*All_ShAll_St, where All is the genome-wide value. Last, the rapidly KEGG pathways were identified using a threshold of P < 0.05 (one-sided binomial test).
Through analysis of conserved genome synteny with goat, we obtained a highly confident set of orthologous genes of mammals (including mouse, human, cat, cheetah, dog, rhinoceros, horse, camel, pig, dolphin, killer whale, and sperm whale) and 51 ruminant species. Domain regions of the encoded proteins were predicted with Pfam (67). Then, we scanned the domain regions in the syntenic alignments and identified the giraffe-specific amino acid substitutions compared to all other species. The substitutions that were not fixed in all published giraffe genomes were further filtered. Last, we identified 414 giraffe genes that have unique substitutions in domain regions, of which 33 genes have more than three unique substitutions (table S17).
The Illumina short reads of giraffe and okapi were mapped onto the cattle genome (UMD3.1). For every gene, the read depth was counted with SAMtools (68) along the coding sequence (CDS). For the CDS region, if more than 50% of the sites had not been mapped with reads in the giraffe, but if more than 50% sites had been mapped with more than 10 reads in okapi, the gene was assumed to be specifically lost in giraffe. It turned out that giraffe uniquely lost 83 genes compared to okapi. To avoid sequencing problem in one research and validate the result, we repeated the same analysis with previously published genomic short reads of another giraffe (9), and it showed that giraffe uniquely lost 78 genes with 63 genes overlapping the result before. However, okapi lost only 13 genes uniquely under the same analysis. We noticed that 53 of the 63 genes lost in giraffe were related to the sense of smell and that they located spatially clustered on chromosomes 10 and 15 on cattle genome (table S18). Furthermore, to validate the result on genome level and to avoid the influence of using cattle genome, we checked the synteny alignment between giraffe-goat (ARS1) and okapi-goat (ARS1), and it verified again that giraffe lost more olfactory-receptor genes on chromosomes 10 and 15 of goat (Fig. 4B and fig. S20). We further checked the deletions on giraffes chromosome 7 (chromosome 10 of goat) with the long Nanopore reads mapped back to the giraffe genome and goat genome; the deletion region can be finely span in giraffe (fig. S21).
Because the 3D structure of the complexes of FGFR1 (a major FGF receptor and was thought to be involved in FGFRL1 signaling) and FGF23 (the ligand) has been revealed (69), we built an in silico 3D structure model of the giraffe FGFRL1 (from IG-II to IG-III domain) by homolog modeling and docked the model with FGF23 to assess possible effects of the mutations on the proteins interaction. The 3D structure model of mtFGFRL1 (seven sites in giraffe type) and WT FGFRL1 (seven sites changed to common type) was separately generated with homolog modeling methods by PROMALS3D (70) with several FGFR structures as templates [Protein Data Bank (PDB) nos. 1E0O, 1EV2, 1II4, 1IIL, 1NUN, 1RY7, 2FDB, 3GRW, 3OJ2, 3OJV, 4J23, and 5W59]. The FGF23 structure was obtained from PDB no. 5w21. The structure of FGFRL1 and FGF23 complexes was produced by the Rosetta (71) protein docking program, using the docking conformation of FGFR1 and FGF23 in PDB no. 5w21 as the initial docking pose.
MD simulations were performed by using the Amber (version 18) software (72) in combination with the ff14SB (version 1.0) force field (73). Protein systems were solvated in the TIP3P water model with an edge distance of 12 , and systems were neutralized (pH 7) by adding suitable counterions (Na+ or Cl). Before performing MD simulations, each system was minimized by means of the steepest descent and conjugate gradient methods through 2000 steps. NPT (constant number of atoms, pressure, and temperature) simulations were then carried out to heat the system from 0 to 300 K using Langevin dynamics for temperature control and the SHAKE algorithm on hydrogen atom constraint. MD simulations were run for 100 ns with the time step set to 2 fs. Last, determination of the relative binding free energy was performed using the molecular mechanics generalized Born surface area method in the Amber package (version 18) (72).
To elucidate the giraffe-type FGFRL1 genes role in skeletogenesis and the cardiovascular system, the seven unique substitutions in giraffe-type FGFRL1 were introduced into the FGFRL1 gene in mice (giraffe-type FGFRL1 mice) by CRISPR-Cas9mediated genome editing as follows. First, single-guide RNA (sgRNA) expression constructs were prepared, based on the pUC57-sgRNA expression vector (no. 51132; Addgene), using oligonucleotide sequences listed in table S21. Next, the sgRNA expression plasmids were linearized and prepared as templates for in vitro transcription using a MEGAshortscript kit (Ambion, AM1354). The sgRNA was purified using a MEGAclear kit (Ambion, AM1908). Fertilized eggs were injected with a mixture of Cas9 protein, sgRNAs, and homologous DNA template. Genomic DNA was then extracted from the tails of 7-day-old mice (new pups) using phenol-chloroform and recovered by alcohol precipitation to detect the mutations. Polymerase chain reaction primers for targeting sites are listed in table S22. Last, mice with expected mutations were mated with WT mice to get enough heterozygous mutant mice, and then homozygous mutant mice were produced by crossing and prepared for consequence experiments.
Neonates (P0) were subjected to whole-mount skeletal staining. Briefly, both P0 WT FGFRL1 (n = 5) and giraffe-type FGFRL1 (n = 5) mice were fixed in 90% ethanol for 12 hours at 4C. Next, specimens were transferred into acetone for 12 hours at room temperature and then into a cartilage staining solution containing 0.03% Alcian blue (w/v; Sigma-Aldrich, USA), 80% ethanol, and 20% acetic acid overnight. The samples were washed with 20% acetic acid, and the ossified tissues were stained in a solution with 0.005% Alizarin red (w/v) overnight at 4C. The specimens were transferred into 1% KOH (w/v) until the muscle tissue was transparent and then saved with 50% glycerol solution containing 1% KOH (w/v). Whole skeleton images were then obtained with an M205 FA stereoscopic microscope (Leica, Germany), and ImageJ software (version 1.46; National Institutes of Health, USA) was used to obtain the following measurements: head length (distance from the frontal tip of the maxilla to the caudal tip of the occipital bone in lateral view), spine length (distance from the annular vertebrae to the tail root), and length of limbs (distance between the two tips of limbs). The measurements were repeated three times for each sample, and average values were obtained.
Adult (16 weeks, 24 to 26 g) WT FGFRL1 mice (n = 8) and giraffe-type FGFRL1 mice (n = 8) were randomly selected and anesthetized by intraperitoneal 1% (w/v) sodium pentobarbital solution (40 mg/kg). The body weight and length (from nose to tail root) of each mouse was measured. Then, x-ray images of the head, lumbar vertebra, and limbs of both sets of mice (n = 3) were acquired using a SkyScan 1276 high-resolution in vivo x-ray microtomography (Bruker, Germany). Digital images were obtained under identical imaging conditions using the same acquisition parameters, and ImageJ software was used to obtain the following measurements: head length (as defined above), height of the L1 lumbar vertebra (distance between the upper and lower endplates of the vertebral body), and length of limbs (as defined above). The measurements were repeated three times for each sample, and average values were obtained.
After x-ray imaging, the adult WT FGFRL1 mice (n = 10) and giraffe-type FGFRL1 mice (n = 10) were sacrificed by an intraperitoneal pentobarbital (Sigma-Aldrich, USA) overdose. The skeleton of each mouse was harvested and fixed by 4.0% formalin. The formalin-fixed femurs and cervical vertebrae were scanned, reconstructed, and analyzed using a GE-LSP industrial microCT system (GE Healthcare, Chicago, IL, USA) with the following parameters: 80 kV, 80 A, and 3.0-s exposure time per projection. The BMD, average trabeculae thickness, and BV/TV of the distal femur (n = 6) and C3 vertebra (n = 10) were measured. In addition, the maximum transverse diameter, average thickness of cortical bone, and both inner and outer perimeters of their femurs (at mid-diaphysis) were measured.
Hypertension was induced using Ang II (Sigma-Aldrich, USA) delivered using Alzet-1004 osmotic mini-pumps (Cupertino, CA). Briefly, WT FGFRL1 and giraffe-type FGFRL1 mice (16 weeks old, 24 to 26 g) were anesthetized with isoflurane (1% at 1.5 liters/min oxygen). A 1-cm incision was then made on the back, and an osmotic mini-pump containing Ang II (n = 10) or an equivalent volume of vehicle (saline, n = 10) was embedded. Ang II (900 ng/kg per minute) was infused at a rate of 10 l/hour for 28 days. At the end of the infusion, the systolic, diastolic, and mean arterial blood pressures were measured using a tail-cuff sphygmomanometer. In addition, cardiac function was evaluated by echocardiography, and hypertension-related cardiac remodeling was examined histologically.
Blood pressure was measured using a BP2010A intelligent noninvasive sphygmomanometer for mice (Softron, Japan), which was calibrated and validated before recording. The reliability of tail-cuff determination of mouse blood pressure was independently validated by radiotelemetry before making critical assessment in mice. Before measurement, mice were acclimated to a restraint box and tail-cuff inflation in a quiet area with designated temperature (22 2C) for 5 days. On the day of testing, mice typically remained relatively calm and still in the restrainer after acclimation period. The tail-cuff was positioned at the base of the tail and a heating pad, supplied as an accessory for the tail-cuff sphygmomanometer, and was preheated to 35C. Blood pressure recordings were acquired after the mice had prewarmed for 10 min. Briefly, the cuff was inflated to 250 mmHg and deflated over 20 s. Ten inflation and deflation cycles were included for each recording. The first three cycles were regarded as acclimation cycles and not included in the analysis. The highest and lowest values in the remaining seven cycles were discarded, and the remaining five readings were averaged for a single session value in further analysis. Changes in tail volume were detected by the pressurized receptor when the blood returned to the tail during cuff deflation. Measurements of the mice were obtained for 3 consecutive days before the Ang II or control treatment to obtain their baseline blood pressure.
Transthoracic echocardiography was performed to evaluate cardiac function using a Vevo 2100 instrument (VisualSonics, Canada) equipped with a 18- to 38-MHz MS-400 imaging sensor. Briefly, the mice were anesthetized with 1% isoflurane via an anesthetic gas machine and maintained in a supine position with limbs fixed, and body temperature was kept stable through a heat pad, while respiration and heart beats were continuously monitored. M-mode images were analyzed to obtain estimates of LVEF, LVFS, left ventricular posterior wall thickness at end diastole, and left ventricular internal diameter at end diastole. For this analysis, a dedicated software (Vevo 2100 version 1.4, VisualSonics, Canada) was used.
At the end of Ang II infusion, the heart (n = 6) and kidney (n = 8) of each vehicle- and Ang IItreated mouse were harvested and fixed with 4.0% formalin (Sigma-Aldrich, USA). Histological sections, 5 m thick, were prepared following standard fixation, clearing, dehydration, waxing, and paraffin-embedding procedures. Representative histological slides were used for histological staining, as follows.
Hematoxylin and eosin staining. The heart and kidney sections were processed by routine dewaxing in xylene followed by hydration with an ethanol concentration gradient. Thereafter, nuclei and cytoplasm in the sections were stained by hematoxylin and eosin (G1004; Servicebio, China), respectively. The sections were then dehydrated, cleared, and mounted. Staining was observed, and images were captured using a BX53+R6 light microscope (Olympus, Tokyo, Japan).
Masson trichrome staining. Heart and kidney tissues were subjected to Masson trichrome staining using a kit and protocols provided by the manufacturer (Sigma-Aldrich, USA). Heart and kidney fibrosis were then measured in terms of the proportion of collagen using ImageJ software. Three randomly selected regions of identical size in each heart or kidney slice were examined, and the average values obtained from them were recorded.
Sirius red staining. The heart sections were stained by incubation in a 0.1% (w/v) solution of Sirius red (G1018; Servicebio, China) in saturated aqueous picric acid for 1 hour. The slides were then washed, dehydrated, and mounted. This treatment stains collagen and noncollagen components red and orange, respectively. Heart fibrosis was measured in terms of the proportion of red-colored collagen using ImageJ software. Three randomly selected regions of identical size in each heart slice were examined, and the average values obtained from them were recorded.
Measurements of continuous variables were expressed as means SD. All statistical analysis was performed with SPSS software (version 19.0; Chicago, USA). Independent Students t tests were used to compare baseline values of WT FGFRL1 and giraffe FGFRL1 mice groups. One-way analysis of variance (ANOVA) was used to compare mean values. If there was a significant overall difference among groups, then Tukeys post hoc test was used for multiple comparisons between groups. A value of P < 0.05 was considered statistically significant.
Acknowledgments: We thank D. Wu for providing the giraffe sample. Funding: This study is supported by the Talents Team Construction Fund of Northwestern Polytechnical University (NWPU) to Q.Q. and W.W., the National Program for Support of Top-notch Young Professionals to Q.Q., the Research Funds for Interdisciplinary Subject, NWPU (19SH030408) to Q.Q., the 1000 Talent Project of Shaanxi Province to Q.Q. and W.W., the National Natural Science Foundation of China (81972052, 81672148, and 81802143) to J.H., and the Independent Research Fund Denmark (8049-00098B) to R.H. Author contributions: Q.Q., J.H., W.W., and R.H. designed this project and research aspects. Zhipeng Li, H.S., G.L., and Q.L. performed sample collection, and D.C. performed sequencing library construction. C.L., L.C., Yuan Yuan, Y.Z., T.Q., M.H., B.Z., Chenglong Zhu, C.Z., and K.W. performed data analysis including genome assembly, annotation, gene family, gene loss, and chromosome evolution. J.G., L.M., and X.C. conducted the experiments for mice. Zihe Li and Y.X. built 3D modeling of proteins. L.Z., Zeshan Lin, Yuan Yin, and W.X. contributed to figure designing. C.L., Q.Q., and J.H. wrote the manuscript. W.W., R.H., and M.T.P.G. performed manuscript amending. Competing interests: J.H., Q.Q., J.G., C.L., and W.W. are inventors on a patent application related to this work filed by the Fourth Military Medical University and the Northwestern Polytechnical University (no. 2020110969712, filed on 14 October 2020). The authors declare no other competing interests. Data and materials availability: All sequencing data and assembled genome have been deposited on the NCBI database with accession ID PRJNA627604. All other data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.
Originally posted here:
A towering genome: Experimentally validated adaptations to high blood pressure and extreme stature in the giraffe - Science Advances
Posted in Genome
Comments Off on A towering genome: Experimentally validated adaptations to high blood pressure and extreme stature in the giraffe – Science Advances
USask Scientists Help Find the Key to Decoding Rye Genome – Seed World
Posted: at 2:56 am
An international team led by the IPK Leibniz Institute in Germany and including University of Saskatchewan (USask) researchers has succeeded in completely decoding the genome of rye, despite its large size and complexity.
Rye is a distinctly climate-resistant cereal plant that is of considerable importance for Germany and northeastern Europe. In Canada, most rye is grown in Saskatchewan and Manitoba.
At USask, the research team includes professor Curtis Pozniak, director of USasks Crop Development Centre and Ministry of Agriculture Strategic Research Program Chair in Durum and High-Yield Wheat Breeding and Genetics, plant molecular geneticist Andrew Sharpe, director of Genomics and Bioinformatics at USasks Global Institute for Food Security (GIFS), Sean Walkowiak (Pozniaks former research officer, now research scientist for Canadian Grain Commission), bioinformatics analyst Brook Byrns, and plant sciences emeritus professor Brian Fowler.
Rye is one of the most cold-tolerant cereal crops and can survive the harshest winters typical of the Canadian Prairies, says Pozniak. The genome sequence of rye points to important genes that could be used to enhance the cold tolerance of other important winter crops, including wheat.
The results published today in the journalNature Geneticsare promising for both science and breeding. Rye offers access to a diverse gene pool, not only for rye breeding but also for wheat breeding.
The delivery of the rye genome represents the work of a large and dedicated group of partners across the world, says Sharpe. These results are significant, as they provide a complete genome that is closely related to other grass crop species such as wheat and barley, thus allowing a deeper insight into the evolutionary relationships between them.
All the research data is available to the general public, meaning the extensive genetic diversity of rye can be systematically discovered and used by breeders in a more targeted approach.
The comparatively low economic importance on a global scale, combined with the great complexity of the genome, interfered with rye getting into the focus of the international research community and thus its genome sequence has been revealed only recently, explains professor Nils Stein, lead of the research group Genomics of Genetic Resources at IPKand holder of a joint professorship at the University of Gttingen.
Rye shares a close and long evolutionary history with barley and wheat. However, its role as an important crop is much shorter. While barley and wheat were domesticated about 10,000 years ago in the so-called Fertile Crescent of the Near East, rye initially spread to Northern Europe as a weed growing in barley and wheat fields. Gradually, rye adopted the characteristics of its two big brothers before becoming a purely cultivated species 5,000-6,000 years ago.
There are important biological differences between rye and its two relatives: rye is fertilized through cross-pollination, thus individual genetic traits cannot be fixed as easily as in a self-fertile plant species, and the rye genome is highly complex, which is mainly due to the large number of highly repeated DNA segments.
Knowing the reference sequence makes it easier to transfer positive properties of rye, such as resistances, to wheat without negatively affecting baking properties, for example.
For example, resistance genes from rye can be transferred to wheat through classical cross-breeding, which has already been used repeatedly in the past, says Stein. Sothe significance of our research extends far beyond rye.
The technical prerequisites for sequencing such a complex genome are available today, Stein emphasizes.
The research used homozygous seeds from the plant breeding company KWS SAAT SE & Co. KGaA.
Thenew genome sequence of our inbred line Lo7 is a great technological achievement and an important step forward towards a more comprehensive genetic characterisation of this crop, says Andres Gordillo, lead of rye breeding at KWS.
It will considerably enhance breeding progress and, therefore, the attractiveness of rye. More specific, it will substantially improve our ability to link resistance traits observed in the field with their underlying genes and their location on the rye genome.
Parallel to the work of the international research team led by Stein, Chinese researchers created a reference sequence of a Chinese landrace.
We worked very well with our Chinese colleagues, which ultimately brought great added value for rye breeding and research. We were able to use two different methods to study two very different rye varieties, of which the complete reference sequences are now available, says Stein.With these two studies, rye has caught up with barley and wheat and is in the middle of the genome research era.
Source: University of Saskatchewan
Read the rest here:
USask Scientists Help Find the Key to Decoding Rye Genome - Seed World
Posted in Genome
Comments Off on USask Scientists Help Find the Key to Decoding Rye Genome – Seed World